GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195,771 | +33.3% | 101,964 | 0.0% | 0.00% | – |
| Q2 2023 | $146,828 | -26.2% | 101,964 | +7.6% | 0.00% | – |
| Q1 2023 | $198,992 | +107.5% | 94,758 | +11.7% | 0.00% | – |
| Q4 2022 | $95,895 | -31.0% | 84,863 | -0.5% | 0.00% | – |
| Q3 2022 | $139,000 | +17.8% | 85,253 | -5.1% | 0.00% | – |
| Q2 2022 | $118,000 | -21.3% | 89,861 | -3.9% | 0.00% | – |
| Q1 2022 | $150,000 | -22.7% | 93,538 | -0.5% | 0.00% | – |
| Q4 2021 | $194,000 | -43.8% | 93,988 | +5.8% | 0.00% | – |
| Q3 2021 | $345,000 | +11.7% | 88,820 | -7.7% | 0.00% | – |
| Q2 2021 | $309,000 | -66.2% | 96,270 | -77.1% | 0.00% | – |
| Q1 2021 | $913,000 | -10.0% | 421,103 | -7.0% | 0.00% | – |
| Q4 2020 | $1,014,000 | -18.6% | 452,957 | -2.8% | 0.00% | – |
| Q3 2020 | $1,245,000 | -17.7% | 465,964 | -5.7% | 0.00% | – |
| Q2 2020 | $1,512,000 | +49.3% | 494,349 | -4.4% | 0.00% | – |
| Q1 2020 | $1,013,000 | -27.7% | 517,034 | +5.4% | 0.00% | – |
| Q4 2019 | $1,402,000 | -22.0% | 490,312 | +0.2% | 0.00% | – |
| Q3 2019 | $1,797,000 | +223.2% | 489,438 | +264.9% | 0.00% | – |
| Q2 2019 | $556,000 | +21.4% | 134,116 | +49.4% | 0.00% | – |
| Q1 2019 | $458,000 | +53.7% | 89,771 | +3.3% | 0.00% | – |
| Q4 2018 | $298,000 | -43.7% | 86,932 | -1.1% | 0.00% | – |
| Q3 2018 | $529,000 | -4.0% | 87,885 | +1.5% | 0.00% | – |
| Q2 2018 | $551,000 | +46.5% | 86,618 | +9.3% | 0.00% | – |
| Q1 2018 | $376,000 | +34.8% | 79,256 | -5.3% | 0.00% | – |
| Q4 2017 | $279,000 | +61.3% | 83,668 | +3.6% | 0.00% | – |
| Q3 2017 | $173,000 | -6.5% | 80,739 | +7.5% | 0.00% | – |
| Q2 2017 | $185,000 | +12.1% | 75,097 | +4.4% | 0.00% | – |
| Q1 2017 | $165,000 | +275.0% | 71,921 | +59.1% | 0.00% | – |
| Q4 2016 | $44,000 | -10.2% | 45,205 | +4.6% | 0.00% | – |
| Q3 2016 | $49,000 | -22.2% | 43,227 | 0.0% | 0.00% | – |
| Q2 2016 | $63,000 | +12.5% | 43,227 | +10.9% | 0.00% | – |
| Q1 2016 | $56,000 | -21.1% | 38,977 | -9.3% | 0.00% | – |
| Q4 2015 | $71,000 | -53.0% | 42,972 | -33.5% | 0.00% | – |
| Q3 2015 | $151,000 | -69.7% | 64,622 | -64.6% | 0.00% | – |
| Q2 2015 | $498,000 | -27.2% | 182,477 | -10.7% | 0.00% | – |
| Q1 2015 | $684,000 | -3.3% | 204,264 | +0.2% | 0.00% | – |
| Q4 2014 | $707,000 | -31.9% | 203,831 | -1.2% | 0.00% | – |
| Q3 2014 | $1,038,000 | +17.3% | 206,394 | +222.2% | 0.00% | – |
| Q2 2014 | $885,000 | +43.7% | 64,057 | +59.2% | 0.00% | – |
| Q1 2014 | $616,000 | +115.4% | 40,242 | +13.6% | 0.00% | – |
| Q4 2013 | $286,000 | -10.6% | 35,417 | +10.3% | 0.00% | – |
| Q3 2013 | $320,000 | – | 32,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |